SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Apple's 'Surprise and Shine' Launch: From iPhone 18 Pro to the First Foldable iPhone and Next-Gen Apple Watch, Here's What to Expect
Stock Market Today: S&P 500, Dow Futures Fall as Oil Tops $99 Despite Trump’s Price Drop Prediction — ASML, NVS, CASY in Focus
Intel Hits 1 Million-Wafer Milestone With ASML’s Next-Gen Chip Technology
5 Stock Picks Last Week From Wall Street's Most Accurate Analysts
Box CEO Aaron Levie Says 'Best Opportunities' In AI are Products That are 'Barely Only Possible' Today
Cantor Fitzgerald Reiterates Neutral on Amgen, Maintains $400 Price Target
Top Economist Slams Trump’s Venezuela Oil Deal ‘Theft’ — ‘Toppled Their Leader’ and ‘Had Him Sign Over Billions’
Needham Reiterates Hold on Appleto Hold
Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Johnson & Johnson To Present Data Across Its Neuropsychiatry Portfolio at 2026 Psych Congress Annual Meeting
BMO Capital Downgrades Amgen to Market Perform, Maintains Price Target to $450
Verizon And Corning Sign Multi-Billion-Dollar Fiber Deal To Expand Broadband And Build AI Infrastructure
AstraZeneca Says Phase 3 DeLLphi-305 Interim Analysis Showed IMFINZI Plus Amgen's Tarlatamab Met Primary Endpoint With Statistically Significant Overall Survival Improvement vs. IM…
This Best Buy Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday
Hormuz Risk, $100 Oil and 4 ETFs Investors Must Watch
Guggenheim Maintains Buy on Merck & Co, Raises Price Target to $170
What's Going On With Arm Holdings Stock Tuesday?
Amgen shares are trading lower amid sympathy with Novartis after that company's pelacarsen phase III trial failed to reach its primary endpoint, with investors assessing the impact…
Roivant Sciences, Pharvaris, IonQ And Other Big Stocks Moving Higher On Tuesday
Apple's Wednesday Event: Pricier iPhone 18 Pros and a $2,099 Foldable Expected